PolyPid to Report Second Quarter 2023 Financial Results and Operational Highlights on August 9, 2023
PETACH TIKVA, Israel, July 26, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company...
Day: July 26, 2023
AC Immune SA Appoints New Chief Medical Officer
AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee memberLausanne,...
Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023
HOUSTON, July 26, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation...
Tilray Brands Reports Record Q4 Financial Results
Record Q4 Net Revenue of $184 Million, Representing 20% Growth Year over Year, $627 Million of Net Revenue for FY2023;...
Palette Life Sciences Enters Into Definitive Agreement with Teleflex Incorporated
Acquisition will accelerate global commercial expansion of the company’s product portfolio, including Barrigel® SANTA BARBARA, Calif. and STOCKHOLM, Sweden, July...
Teleflex to Acquire Palette Life Sciences
Acquisition will add Barrigel®, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolioWAYNE, Pa., July 26, 2023 (GLOBE NEWSWIRE)...
Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies...
ALSA Ventures launches Vantage Biosciences to treat Diabetic Eye Disease
Diabetic eye diseases are the leading cause of blindness in the working age populationVX-01 is an oral therapy – current...
RETRANSMISSION: NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry
Toronto, Ontario--(Newsfile Corp. - July 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased...
LivaNova Reports Second-Quarter 2023 Results
LONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended June 30, 2023...
FendX Announces Investor Relations Agreement
Oakville, Ontario--(Newsfile Corp. - July 26, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX")...